Back to Nuveen Asset Management, LLC Nuveen Asset Management, LLC

AXSMAXSM

Showing 2 of 23 quarters

Position history for Nuveen Asset Management, LLCNuveen Asset Management, LLC's holdings in Axsome Therapeutics, Inc.

As of its last 13F, for Q4 2024, Nuveen Asset Management held 221,202 shares of AXSM (Axsome Therapeutics), worth $18.7M. It increased the position by 119,780 shares (+118.1%) from Q3 2024. Nuveen Asset Management held AXSM from Q2 2019 to Q4 2024, across 23 quarterly 13F filings.

Current Value

$18.7M

Current Shares

221,202

Total Value Change

+$9.6M

Total Shares Change

+119,780

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Increased
221,202
+118.1%
$18.7M0.0%$84.61
46
2024-Q3
Decreased
101,422
-1.2%
$9.1M0.0%$89.87
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used